Brivepsy 25mg Tablet
Marketer
Cipla Ltd
Salt Composition
Brivaracetam (25mg)
Overview Brivepsy 25mg Tablet
Epileptin 25mg tablets are an anticonvulsant medication prescribed to manage epileptic seizures. This medication can be administered independently or in conjunction with other treatments. Consistent use is crucial for sustained seizure control. Epileptin 25mg tablets regulate abnormal brain electrical activity. Take this medication regularly, with or without food, but maintain a consistent daily schedule for optimal efficacy. Dosage and frequency are determined by your physician to effectively manage your seizures, potentially increasing gradually. Long-term therapy is typically recommended. Continue taking it as prescribed, even if you feel well; discontinuation or missed doses may exacerbate seizures. Never cease treatment without your doctor's instruction, as abrupt cessation can worsen seizures. Common side effects include dizziness, headache, nausea, and vomiting. Behavioral changes, such as aggression, irritability, and agitation, may also occur. Side effects are often more pronounced initially, generally diminishing with continued use. While most side effects require no intervention, some may be severe. Suicidal ideation has been reported in a small percentage of patients. Report any worsening mood changes to your doctor immediately. Prior to commencing treatment, inform your doctor of any liver or kidney conditions, depressive disorders, suicidal thoughts, pregnancy, or pregnancy plans. Nursing mothers should also seek medical advice before using this medication.
Uses of Brivepsy 25mg Tablet
Convulsive disorders
Major Benefits of Brivepsy 25mg Tablet:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment duration. Ingest the 25mg Brivepsy tablet whole; avoid chewing, crushing, or fracturing it. Consumption may coincide with meals or not, but consistent timing is recommended.
Common Side effects of Brivepsy 25mg Tablet:
- Behavioral changes
- Agitation
- Aggressive behavior
- Dizziness
- Sedation
- Drowsiness
- Neuropsychiatric symptoms
How to use Brivepsy 25mg Tablet:
Administer this medication precisely as prescribed by your physician, adhering to the recommended dosage and treatment period. Ingest the 25mg Brivepsy tablet whole; avoid chewing, crushing, or fracturing it. Consumption with or without food is acceptable, although consistent daily timing is preferred.
How Brivepsy 25mg Tablet works:
Nerivia 25mg tablets are prescribed to manage epilepsy. Their mechanism involves binding to specialized receptors (SV2A) located on neuronal membranes. This action inhibits irregular neuronal firing within the brain, thereby preventing the propagation of seizure-inducing electrical impulses.
SAFETY ADVICE
AlcoholUNSAFE
Combining Brivepsy 25mg Tablet with alcohol is inadvisable.
PregnancyCONSULT YOUR DOCTOR
Using Brivepsy 25mg tablets during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to a developing fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice before use.
Breast feedingCONSULT YOUR DOCTOR
Data on the use of Brivepsy 25mg Tablet while breastfeeding is lacking. Seek your physician's advice.
DrivingUNSAFE
Taking a Brivepsy 25mg Tablet might cause drowsiness, blurred vision, and dizziness, reducing alertness. Refrain from driving if you experience these effects.
KidneySAFE IF PRESCRIBED
Brivepsy 25mg tablets may be used in patients with kidney impairment without dosage modification. However, its use is contraindicated in end-stage renal disease, given the absence of supporting clinical trial evidence.
LiverCAUTION
Patients with hepatic impairment should exercise caution when using Brivepsy 25mg tablets, as dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Brivepsy 25mg Tablet :
NA
Facts to Know About Brivepsy 25mg Tablet
| Label | Value |
|---|---|
| Chemical Type | Levetiracetam Analog |
| Developing Habits | No. |
| Treatment Category | Neuroscience of the Central Nervous System |
| Actions | AED: A protein ligand bound to synaptic vesicle 2 |



